Form 8-K - Current report:
SEC Accession No. 0000950170-23-014246
Filing Date
2023-04-25
Accepted
2023-04-25 07:57:44
Documents
13
Period of Report
2023-04-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cue-20230419.htm   iXBRL 8-K 71053
  Complete submission text file 0000950170-23-014246.txt   213429

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cue-20230419.xsd EX-101.SCH 2917
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cue-20230419_pre.xml EX-101.PRE 13511
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cue-20230419_def.xml EX-101.DEF 13504
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cue-20230419_lab.xml EX-101.LAB 16077
7 EXTRACTED XBRL INSTANCE DOCUMENT cue-20230419_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 23841787
SIC: 2834 Pharmaceutical Preparations